Everus Construction Group (ECG) operates as a specialty contracting and construction-solutions provider through its Electrical & Mechanical and Transmission & Distribution segments. Throughout 2026 the company has benefited from strong demand tied to data-center infrastructure, high-tech manufacturing facilities, and power transmission work, while integrating recent acquisitions including SE&M and Epsilon Industries. Before this earnings release the stock had retreated from its peaks despite earlier guidance increases, so the third-quarter results served as an important test of whether the elevated backlog would support sustained earnings growth. From what I see, this quarter provided a useful check on margins, backlog conversion, and the reliability of the updated outlook.
Everus reported third-quarter 2026 revenue of $1.38 billion, up 39.8% from $986.8 million in the same period a year earlier and ahead of the consensus estimate of roughly $1.19 billion. GAAP diluted EPS reached $1.79, exceeding the consensus estimate of about $1.28 and improving from $1.11 in the prior-year quarter. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Net income for the quarter was approximately $91.9 million, compared with about $57.0 million a year ago. For the first nine months of 2026, revenue reached $3.65 billion, net income climbed 59.8% to $234.1 million, and diluted EPS rose to $4.57 from $2.87. Adjusted EBITDA increased 52.2% to $357.7 million for the nine-month period, with the EBITDA margin expanding to 9.8% from 8.6%.
Given the strong first three quarters and completed acquisitions, management raised its full-year 2026 guidance. The company now expects revenue of $5.0 billion to $5.1 billion, up from the prior range of $4.5 billion to $4.7 billion, and adjusted EBITDA of $485 million to $495 million, up from $410 million to $425 million.
Sentiment ahead of the report had grown cautious. Everus shares had declined roughly 35% from their post-guidance highs, even as management issued consecutive outlook increases, leaving the stock near its post-report low and below its 200-day moving average. The combination of a quarterly revenue record, an EPS beat, and a second guidance raise helped improve the tone, with shares trading higher in the session after the release. Investors focused most on the durability of demand signals and the company’s confidence in lifting its full-year targets.
Looking ahead, investors will watch whether Everus can maintain momentum into the fourth quarter and convert its elevated backlog into revenue and profit. The company had previously indicated that back-half margins would moderate from the second quarter’s elevated levels, so any indication that margins hold above plan would support confidence in pricing power and project execution.
Backlog composition will stay in focus. Management has noted that recent growth has not been driven solely by data centers, and continued diversification across commercial, industrial, and semiconductor work would help address concentration concerns. Progress on the Epsilon Industries and SE&M integrations will also matter, as will any updates on labor, material, and tariff-related cost pressures that could affect margins on fixed-price contracts.
Finally, cash-flow trends deserve attention. Strong first-half free cash flow benefited from working-capital timing that management expects to reverse, so a softer third-quarter figure on its own may not signal a problem. Overall, the key question remains whether Everus can show that its record demand leads to durable, broad-based earnings power rather than a temporary data-center-driven surge.
In my own research process I often turn to Tickeron’s AI-powered tools to cross-check patterns and compare opportunities across the sector. One resource I find particularly helpful is the AI Screener, which lets users apply filters for technical patterns, fundamentals, and performance metrics to surface comparable ideas more efficiently. It has become a regular part of how I evaluate names like Everus Construction Group (ECG) alongside peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
ECG's Aroon Indicator triggered a bullish signal on October 14, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator showed a similar pattern. In 118 of the 131 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ECG's RSI Oscillator exited the oversold zone, 3 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 14 of 17 cases where ECG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +6.19% 3-day Advance, the price is estimated to grow further. Considering data from situations where ECG advanced for three days, in 104 of 121 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ECG as a result. In 26 of 38 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 68%.
The Moving Average Convergence Divergence Histogram (MACD) for ECG turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In 13 of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.
ECG moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ECG crossed bearishly below the 50-day moving average on October 15, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ECG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
ECG broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 26 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.802) is normal, around the industry mean (15.267). P/E Ratio (20.681) is within average values for comparable stocks, (166.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.522). Dividend Yield (0.000) settles around the average of (0.198) among similar stocks. P/S Ratio (1.335) is also within normal values, averaging (2.856).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. ECG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ECG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry EngineeringConstruction